{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:08:56Z","timestamp":1790622536750,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1053\/j.ajkd.2017.04.026","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T02:16:55Z","timestamp":1498184215000},"page":"581-585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Nephrotic Syndrome With Cancer Immunotherapies: A\u00a0Report\u00a0of\u00a02 Cases"],"prefix":"10.1053","volume":"70","author":[{"given":"Abhijat","family":"Kitchlu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Fingrut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Avila-Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher T.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Crump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather N.","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1053\/j.ajkd.2017.04.026_bib1","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1053\/j.ajkd.2017.04.026_bib2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1053\/j.ajkd.2017.04.026_bib3","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ki.2015.30","article-title":"New drug toxicities in the onco-nephrology world","volume":"87","author":"Perazella","year":"2015","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2017.04.026_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMc0904283","article-title":"Anti-CTLA4 antibody-induced lupus nephritis","volume":"361","author":"Fadel","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2017.04.026_bib5","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1097\/MJT.0b013e3182a32ddc","article-title":"Ipilimumab granulomatous interstitial nephritis","volume":"22","author":"Thajudeen","year":"2015","journal-title":"Am J Ther"},{"issue":"3","key":"10.1053\/j.ajkd.2017.04.026_bib6","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.kint.2016.04.008","article-title":"Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors","volume":"90","author":"Cortazar","year":"2016","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2017.04.026_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.ajkd.2016.02.057","article-title":"Association of acute interstitial nephritis with programmed cell death 1 inhibitor therapy in lung cancer patients","volume":"68","author":"Shirali","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2017.04.026_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.1986.209","article-title":"Neoplasia and glomerular injury","volume":"30","author":"Alpers","year":"1986","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2017.04.026_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0002-9343(86)90049-5","article-title":"Glomerular lesions in lymphomas and leukemias","volume":"80","author":"Dabbs","year":"1986","journal-title":"Am J Med"},{"issue":"suppl 6","key":"10.1053\/j.ajkd.2017.04.026_bib10","first-page":"vi52","article-title":"Secondary minimal change disease","volume":"18","author":"Glassock","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2017.04.026_bib11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000013365","article-title":"Recovery of minimal change nephrotic syndrome and acute renal failure in a patient with renal cell carcinoma","volume":"18","author":"Auguet","year":"1998","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2017.04.026_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000168592","article-title":"Minimal-change glomerulopathy and carcinoma. Report of two cases and review of the literature","volume":"13","author":"Martinez-Vea","year":"1993","journal-title":"Am J Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2017.04.026_bib13","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/sj.ki.5000341","article-title":"Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature","volume":"69","author":"Audard","year":"2006","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2017.04.026_bib14","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.kint.2015.11.028","article-title":"Ipilimumab-associated minimal-change disease","volume":"89","author":"Kidd","year":"2016","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2017.04.026_bib15","first-page":"37","article-title":"A\u00a0vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome","volume":"23","author":"Lagrue","year":"1975","journal-title":"Biomedicine"},{"issue":"11","key":"10.1053\/j.ajkd.2017.04.026_bib16","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.2215\/CJN.03800609","article-title":"Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis","volume":"5","author":"McCarthy","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2017.04.026_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000045645","article-title":"Interleukin-18 and interleukin-12 synergize to stimulate the production of vascular permeability factor by T lymphocytes in normal subjects and in patients with minimal-change nephrotic syndrome","volume":"85","author":"Matsumoto","year":"2000","journal-title":"Nephron"},{"issue":"2","key":"10.1053\/j.ajkd.2017.04.026_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000045898","article-title":"Transforming growth factor-beta1 inhibits vascular permeability factor release by T cells in normal subjects and in patients with minimal-change nephrotic syndrome","volume":"87","author":"Matsumoto","year":"2001","journal-title":"Nephron"},{"issue":"10","key":"10.1053\/j.ajkd.2017.04.026_bib19","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI20402","article-title":"Induction of B7-1 in podocytes is associated with nephrotic syndrome","volume":"113","author":"Reiser","year":"2004","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1053\/j.ajkd.2017.04.026_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.immuni.2007.05.016","article-title":"Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses","volume":"27","author":"Butte","year":"2007","journal-title":"Immunity"},{"issue":"25","key":"10.1053\/j.ajkd.2017.04.026_bib21","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","article-title":"Abatacept in B7-1-positive proteinuric kidney disease","volume":"369","author":"Yu","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2017.04.026_bib22","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1681\/ASN.2015030266","article-title":"B7-1 is not induced in podocytes of human and experimental diabetic nephropathy","volume":"27","author":"Gagliardini","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2017.04.026_bib23","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1053\/j.ajkd.2014.07.023","article-title":"B7-1 immunostaining in proteinuric kidney disease","volume":"64","author":"Larsen","year":"2014","journal-title":"Am J Kidney Dis"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638617307357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638617307357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:58:05Z","timestamp":1759460285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638617307357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0272638617307357"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2017.04.026","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nephrotic Syndrome With Cancer Immunotherapies: A\u00a0Report\u00a0of\u00a02 Cases","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2017.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}